Stay Informed

Featured Articles

Pfizer to Provide U.S. Government with 10 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-19 (December 2021)

The Truth About COVID-19 and Black Fungus (December 2021)

Pfizer's Commitment to Supplier Diversity (December 2021)

For Education, Support, and Assistance, Patient Advocacy Groups Can Help (December 2021)

Anatomy of a Clinical Trial: The Purpose, People, and Phases of Clinical Research (December 2021)

Shot of a Lifetime (October 2021)

Pandemic Lessons Can Help Us Shape a Smarter Care Continuum (October 2021)

Science Will Win Podcast (October 2021)

Feeling Sick? (October 2021)

Responding to the Crises in Haiti, the United States and Afghanistan (September 2021)

Why Foreign Drug Pricing Policies Don't Work (September 2021)

Our Firsts: Marking the Milestones in The Relentless Fight Against COVID-19 (September 2021)

Your Health: Sickle Cell (September 2021)

Ramcess Jean-Louis is Ready to Build on Pfizer's Longtime Commitment to Diversity, Equity, and Inclusion (September 2021)

How 10 Biopharma Companies are Working Together to Bring Medicines to Patients Faster (August 2021)

Advancing Our Protease Inhibitors (August 2021)

Translating Technical Language into Plain Language for Clinical Trials (August 2021)

Where Do Pandemics Come From? (August 2021)

mRNA – Technology at the Forefront During Global Pandemic (July 2021)

Empowering Patients by Closing the Health Literacy Gap (July 2021)

A "Ticklist" for Staying Safe While Spending Time Outdoors (July 2021)

New Hope for a Once Neglected Disease: Advances in Sickle Cell Treatments (July 2021)

An Open Letter from Pfizer Chairman and CEO to Colleagues (June 2021)

Partnering to RETHINK Vaccine Confidence and RE:SET Mental Health Among Black Nurses (June 2021)

Reimagining Primary Healthcare in Bogor, Indonesia (June 2021)

Advances in Cytomegalovirus Vaccine Development (June 2021)

Supporting India in Its Time of Need (May 2021)

Meet Dacia Young, a Senior Associate Scientist Within the Vaccine Research and Development Group at Pfizer (May 2021)

An Immune System “GPS” Uncovers Pathways to Treat Diseases (May 2021)

Is Remote Clinical Trial Monitoring Here to Stay? (May 2021)

COVID-19 as a Catalyst for Modernizing Clinical Trials (May 2021)

Albert Bourla Reflects on the One Year Anniversary of the COVID-19 Pandemic (April 2021)

Annual Review Highlights a Historic Year (April 2021)

Pfizer Initiates Phase 1 Study of Novel Oral Antiviral Therapeutic Agent Against SARS-CoV-2 (April 2021)

Biosimilars: Advancing Science to Help Improve Patient Access to Medicines (April 2021)

Real-world Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared (April 2021)

Global Survey Results: Cancer & Aging (March 2021)

Setting the Stage for a Fight: Enlisting T-cells to Combat Multiple Myeloma (March 2021)

The Potential of Antivirals (March 2021)

From Outbreak to Immunity (March 2021)

Pfizer Initiates Pivotal Phase 2 Magnetismm-3 Trial of BCMA-CD3 Bispecific Antibody Elranatamab (PF-06863135) in Multiple Myeloma (March 2021)

Pfizer and Biontech Submit COVID-19 Vaccine Stability Data at Standard Freeze Temperature to the U.S. FDA (March 2021)

The Facts About Pfizer and BioNTech's COVID-19 Vaccine (February 2021)

How do Viruses Make us Sick? (February 2021)

Albert Bourla on Ensuring Equitable Access to COVID-19 Vaccines (January 2021)

A New Pfizer (January 2021)

Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19 (December 2020)

Working to Develop a More Safe and Convenient Treatment Option for Patients with Rare Platelet Disorder (December 2020)

Cancer Doesn't Wait: Why People Need to Get Back to Cancer Screenings and Follow-up Appointments (December 2020)

COVID-19 Vaccine Development (November 2020)

Albert Bourla Discusses COVID-19 Vaccine Efficacy Results (November 2020)

Coronavirus and Immunity: Key Questions as Society Begins to Reopen (October 2020)

Empowering People with 'Super Genes' to Help Unlock New Treatment Pathways (October 2020)

The Antigen Podcast Season 2 (August 2020)

New Pathways to Cachexia Treatment: Focusing on Patient Quality of Life (August 2020)

Age: Addressing a Blind Spot in Cancer Care (July 2020)

The 14-Day Quarantine: Understanding the Coronavirus Incubation Period (July 2020)

The Antigen Podcast Season 2 (June 2020)

Uncovering New Biomarkers to Better Understand Friedreich’s Ataxia (June 2020)

Sweet Science: How Insights into Fructose Metabolism Are Helping to Fight Liver Disease (June 2020)

What Makes an RNA Vaccine Different From a Conventional Vaccine? (May 2020)

AI in Drug Safety: Building the Elusive ‘Loch Ness Monster’ of Reporting Tools (May 2020)

Joining Forces to Share Data to Fight COVID-19 (May 2020)

BioNTech and Pfizer Announce Regulatory Approval from German Authority Paul-Ehrlich-Institut to Commence First Clinical Trial of COVID-19 Vaccine Candidates (April 2020)

4 Things to Know About the Science of Coronavirus (April 2020)

All Hands on Deck as Scientists Revive SARS Protease Inhibitor to Attempt to Fight COVID-19 (April 2020)

Managing Your Mental Health During a Pandemic (April 2020)

Pfizer Outlines Five-Point Plan to Battle COVID-19 (March 2020)

Pfizer & BioNTech to Co-Develop Potential COVID-19 Vaccine (March 2020)

Racing to Develop a Potential COVID-19 Vaccine with Unprecedented Partnership (March 2020)

Get Science Podcast: The Next Generation of Scientists Learn the Ropes of the Industry (February 2020)

The Rise of RNA: The Cellular Workhorse Behind a New Class of Next-Gen Therapies (February 2020)

Taking a New Tack for Next-Generation IBD Treatments (February 2020)

In Conversation with the Data Hippie: Using Real World Evidence for Better Medicines (January 2020)

The Future of Flu Season: How RNA Technology Could Revolutionize Vaccine Production (January 2020)

Breakthroughs that Change Patients’ Lives (January 2020)